A Randomized, Double-blind, Placebo-Controlled, Repeat-dose, Single-center Phase 1a Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Subjects
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009406/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study to evaluate the safety, tolerability and pharmacokinetics (PK) of
lanadelumab administered by Intravenous (IV) infusion in healthy adult volunteers.
提供机构：
Vivli
创建时间：
2023-11-01
